» Articles » PMID: 27167232

Stereotactic Body Radiation Therapy of Liver Tumors: Post-treatment Appearances and Evaluation of Treatment Response: a Pictorial Review

Overview
Publisher Springer
Date 2016 May 12
PMID 27167232
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Stereotactic body radiation therapy (SBRT) is a noninvasive treatment technique for selected patients with primary liver tumors and liver-confined oligometastatic disease. Recently, SBRT has emerged as an alternative treatment option in non-surgical candidates and in whom percutaneous treatment methods are not possible or contraindicated. The experience with SBRT continues to grow. There are currently no imaging guidelines for assessment of tumor response and follow-up schedule following SBRT. SBRT produces characteristic radiation-induced changes in the treated tumor and surrounding liver parenchyma. Knowledge of these changes is essential in the interpretation of follow-up imaging and assessment of treatment response. In this review, we will describe the CT, MRI, and PET imaging findings following SBRT of both the targeted liver tumor and surrounding hepatic parenchyma.

Citing Articles

Pseudoprogression Following Liver Stereotactic Body Radiotherapy (SBRT) in a Patient With Oligometastatic Leiomyosarcoma: A Case Report.

Aly M, Shahhat S, Nguyen T Cureus. 2024; 16(8):e67835.

PMID: 39323699 PMC: 11424013. DOI: 10.7759/cureus.67835.


Tumor Response on Diagnostic Imaging after Proton Beam Therapy for Hepatocellular Carcinoma.

Niitsu H, Mizumoto M, Li Y, Nakamura M, Ishida T, Iizumi T Cancers (Basel). 2024; 16(2).

PMID: 38254846 PMC: 10814092. DOI: 10.3390/cancers16020357.


Local Control Following Stereotactic Body Radiation Therapy for Liver Oligometastases: Lessons from a Quarter Century.

Mheid S, Allen S, Ng S, Hall W, Sanford N, Aguilera T Curr Oncol. 2023; 30(10):9230-9243.

PMID: 37887567 PMC: 10605011. DOI: 10.3390/curroncol30100667.


Liver parenchymal changes detected by MR elastography and diffusion-weighted imaging after stereotactic body radiotherapy for hepatocellular carcinoma.

Omiya Y, Morisaka H, Matsuda M, Saito M, Hashimoto T, Motosugi U Abdom Radiol (NY). 2023; 48(11):3353-3361.

PMID: 37542553 DOI: 10.1007/s00261-023-03995-x.


Response evaluation of hepatocellular carcinoma treated with stereotactic body radiation therapy: magnetic resonance imaging findings.

Mai Z, Yang Q, Xu J, Xie H, Ban X, Xu G Abdom Radiol (NY). 2023; 48(6):1995-2007.

PMID: 36939911 PMC: 10167191. DOI: 10.1007/s00261-023-03827-y.